{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:51:59Z","timestamp":1790257919891,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["vaajournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Anaesthesia and Analgesia"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.vaa.2021.08.003","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T14:36:44Z","timestamp":1630161404000},"page":"900-905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Concentrations of vatinoxan and xylazine in plasma, cerebrospinal fluid and brain tissue following intravenous administration in sheep"],"prefix":"10.1016","volume":"48","author":[{"given":"Magdy","family":"Adam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jere","family":"Lind\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"Raekallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abu-Shahba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Mannerstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Sepp\u00e4nen-Kaijansinkko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Meller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Salla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaa.2021.08.003_bib1","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2460\/ajvr.79.9.921","article-title":"Effects of the peripherally acting \u03b12-adrenoceptor antagonist MK-467 on cardiopulmonary function in sheep sedated by intramuscular administration of medetomidine and ketamine and reversed by intramuscular administration of atipamezole","volume":"79","author":"Adam","year":"2018","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaa.2021.08.003_bib2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/jvp.12486","article-title":"The impact of MK-467 on plasma drug concentrations, sedation and cardiopulmonary changes in sheep treated with intramuscular medetomidine and atipamezole for reversal","volume":"41","author":"Adam","year":"2018","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.vaa.2021.08.003_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.tvjl.2018.07.007","article-title":"Cardiopulmonary effects of vatinoxan in sevoflurane-anaesthetised sheep receiving dexmedetomidine","volume":"238","author":"Adam","year":"2018","journal-title":"Vet J"},{"key":"10.1016\/j.vaa.2021.08.003_bib4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/jvp.12292","article-title":"Effects of MK-467 on the antinociceptive and sedative actions and pharmacokinetics of medetomidine in dogs","volume":"39","author":"Bennett","year":"2016","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.vaa.2021.08.003_bib5","first-page":"318","article-title":"The role of active transport in the transcellular movement of the peripheral \u03b12-adrenoceptor antagonist, MK-467: an in\u00a0vitro pilot study","volume":"81","author":"Bennett","year":"2017","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.vaa.2021.08.003_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0034-5288(98)90167-9","article-title":"Characterisation of the cardiovascular pharmacology of medetomidine in the horse and sheep","volume":"65","author":"Bryant","year":"1998","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaa.2021.08.003_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.575","article-title":"Applicability of free drug hypothesis to drugs with good membrane permeability that are not efflux transporter substrates: a microdialysis study in rats","volume":"8","author":"Chen","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.vaa.2021.08.003_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0022-3565(25)22301-1","article-title":"A\u00a0peripherally acting alpha-2 adrenoceptor antagonist: L-659,066","volume":"245","author":"Clineschmidt","year":"1988","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.vaa.2021.08.003_bib9","series-title":"Dexdomitor \u2013 Scientific Discussion","year":"2005"},{"key":"10.1016\/j.vaa.2021.08.003_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.vaa.2016.08.011","article-title":"The impact of MK-467 on sedation, heart rate and arterial blood pressure after intramuscular coadministration with dexmedetomidine in conscious cats","volume":"44","author":"Honkavaara","year":"2017","journal-title":"Vet Anaesth Analg"},{"key":"10.1016\/j.vaa.2021.08.003_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/vaa.12385","article-title":"The effect of MK-467, a peripheral \u03b12-adrenoceptor antagonist, on dexmedetomidine-induced sedation and bradycardia after intravenous administration in conscious cats","volume":"44","author":"Honkavaara","year":"2017","journal-title":"Vet Anaesth Analg"},{"key":"10.1016\/j.vaa.2021.08.003_bib12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1467-2995.2008.00403.x","article-title":"The effects of L-659,066, a peripheral \u03b12-adrenoceptor antagonist, on dexmedetomidine-induced sedation and bradycardia in dogs","volume":"35","author":"Honkavaara","year":"2008","journal-title":"Vet Anaesth Analg"},{"key":"10.1016\/j.vaa.2021.08.003_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vaa.2019.07.004","article-title":"Concentrations of medetomidine enantiomers and vatinoxan, an \u03b12-adrenoceptor antagonist, in plasma and central nervous tissue after intravenous coadministration in dogs","volume":"47","author":"Honkavaara","year":"2020","journal-title":"Vet Anaesth Analg"},{"key":"10.1016\/j.vaa.2021.08.003_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2460\/ajvr.81.4.299","article-title":"Investigation of the effects of vatinoxan on somatic and visceral antinociceptive efficacy of medetomidine in dogs","volume":"81","author":"Huuskonen","year":"2020","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaa.2021.08.003_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2885.2003.00492.x","article-title":"Pharmacokinetics and sedative effects of intramuscular medetomidine in domestic sheep","volume":"26","author":"K\u00e4stner","year":"2003","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.vaa.2021.08.003_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/138920008783331077","article-title":"CSF as a surrogate for assessing CNS exposure: an industrial perspective","volume":"9","author":"Lin","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.vaa.2021.08.003_bib17","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1124\/dmd.105.008201","article-title":"Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration","volume":"34","author":"Liu","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.vaa.2021.08.003_bib18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2885.2009.01156.x","article-title":"The effects of L-659,066, a peripheral \u03b12-adrenoceptor antagonist, and verapamil on the cardiovascular influences of dexmedetomidine in conscious sheep","volume":"33","author":"Raekallio","year":"2010","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.vaa.2021.08.003_bib19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1528-1167.2006.00504.x","article-title":"Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy","volume":"47","author":"Rambeck","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.vaa.2021.08.003_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1467-2995.2011.00630.x","article-title":"Effects of different doses of L-659'066 on the bispectral index and clinical sedation in dogs treated with dexmedetomidine","volume":"38","author":"Restitutti","year":"2011","journal-title":"Vet Anaesth Analg"},{"key":"10.1016\/j.vaa.2021.08.003_bib21","first-page":"49","article-title":"Pharmacokinetics of medetomidine","volume":"85","author":"Salonen","year":"1989","journal-title":"Acta Vet Scand Suppl"},{"key":"10.1016\/j.vaa.2021.08.003_bib22","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.addr.2004.07.011","article-title":"Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics","volume":"56","author":"Shen","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaa.2021.08.003_bib23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrd3287","article-title":"The effect of plasma protein binding on in\u00a0vivo efficacy: misconceptions in drug discovery","volume":"9","author":"Smith","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaa.2021.08.003_bib24","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1080\/00498254.2018.1539278","article-title":"Antiretroviral concentrations and surrogate measures of efficacy in the brain tissue and CSF of preclinical species","volume":"49","author":"Srinivas","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.vaa.2021.08.003_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/vaa.12012","article-title":"Plasma drug concentrations and clinical effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in horses sedated with detomidine","volume":"40","author":"Vainionp\u00e4\u00e4","year":"2013","journal-title":"Vet Anaesth Analg"}],"container-title":["Veterinary Anaesthesia and Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146729872100204X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146729872100204X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T02:59:38Z","timestamp":1761447578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S146729872100204X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S146729872100204X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaa.2021.08.003","relation":{},"ISSN":["1467-2987"],"issn-type":[{"value":"1467-2987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concentrations of vatinoxan and xylazine in plasma, cerebrospinal fluid and brain tissue following intravenous administration in sheep","name":"articletitle","label":"Article Title"},{"value":"Veterinary Anaesthesia and Analgesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaa.2021.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of Association of Veterinary Anaesthetists and American College of Veterinary Anesthesia and Analgesia.","name":"copyright","label":"Copyright"}]}}